Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Operating Expenses history
Currency unavailable · from the income statement
No Operating Expenses data reported for this period type.
Operating Expenses vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.76B USD | +35.1% | +36.8% | 155.1% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 286.68M SEK | +4.9% | +16.4% | 21555.4% |
| LTM Mar 2026 | $260.65M USD | +81.1% | +32.8% | 72.2% | |
| LTM Mar 2026 | $111.44M USD | +28.9% | +4.1% | 95.2% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | +32.0% | +24.6% | 125.2% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.